Drugs and clinical trials in neurodegenerative diseases
Neurodegenerative diseases are disabling conditions continuously increasing due to aging of population. A disease modifying therapy that slows or stops disease progression is therefore a major unmet medical need. Unfortunately, research for effective treatments is hampered by lack of knowledge on th...
Saved in:
Main Authors: | Paolo Stanzione (Author), Domenicantonio Tropepi (Author) |
---|---|
Format: | Book |
Published: |
Istituto Superiore di Sanità,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Old Drugs as New Treatments for Neurodegenerative Diseases
by: Fernando Durães, et al.
Published: (2018) -
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
by: Stéphanie Andrade, et al.
Published: (2023) -
Need to improve clinical trials in rare neurodegenerative disorders
by: Maria Puopolo, et al.
Published: (2011) -
Neurodegenerative Diseases
Published: (2023) -
Neurodegenerative Diseases
Published: (2013)